← 產業報告目錄
Neurogenomics Market Size, Share & Trends Analysis Report By Offering (Next-Generation Sequencing (NGS) Systems, Kits & Reagents; DNA Extraction And Amplification Kits & Reagents; Library Preparation And Target Enrichment Kits & Reagents; Quality Control Kits & Reagents; Other NGS Kits & Reagents; Polymerase Chain Reaction (PCR) Systems, Kits & Reagents; Microarrays; Readers & Scanners; DNA/RNA, Protein, And Tissue Microarray Kits & Reagents; Software & Services), By Application, By End-user, by Region, And by Segment Forecasts, 2025-2034.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-18頁數 180報告編號 INSIGHTACE-6df01ae63d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Neurogenomics Market stood at USD 1.7 Bn in 2024, and is anticipated to reach USD 7.3 Bn by 2034, recording a CAGR of 16.2% from 2025 through 2034.
The Neurogenomics sector involves study of how an organism's genome influences the development, structure, and function of its nervous system. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is bolstered by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neurogenomics Market Snapshot
Chapter 4. Global Neurogenomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Neurogenomics Market Industry Trends
4.10. Global Neurogenomics Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Neurogenomics Market Segmentation 1: By Offering, Estimates & Trend Analysis
5.1. Market Share by Offering, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Offering:
5.2.1. Next-Generation Sequencing (NGS)
5.2.1.1. Systems
5.2.1.2. Kits & Reagents
5.2.1.2.1. DNA Extraction and Amplification Kits & Reagents
5.2.1.2.2. Library Preparation and Target Enrichment Kits & Regents
5.2.1.2.3. Quality Control Kits & Reagents
5.2.1.2.4. Other NGS Kits & Reagents
5.2.2. Polymerase Chain Reaction (PCR)
5.2.2.1. Systems
5.2.2.2. Kits & Reagents
5.2.2.2.1. Microarray+
5.2.2.2.2. Readers & Scanners
5.2.2.2.3. DNA and RNA Microarray Kits & Reagents
5.2.2.2.4. Protein Microarray Kits & Reagents
5.2.2.2.5. Tissue Microarray Kits & Reagents
5.2.3. Software & Services
Chapter 6. Neurogenomics Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Research Applications
6.2.2. Target Identification
6.2.3. Functional Studies
6.2.4. Variant Discovery
6.2.5. Transcription Factor Binding Analysis
6.2.6. Clinical Applications
Chapter 7. Neurogenomics Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Academic & Research Institutes
7.2.3. Hospitals & Diagnostic Laboratories
Chapter 8. Neurogenomics Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Neurogenomics Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.2.3. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.3.3. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.4.3. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.5.3. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2021-2034
8.6.3. Middle East & Africa Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Neurogenomics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Illumina, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Offering/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. F. Hoffmann-La Roche Ltd (Switzerland)
9.2.4. Qiagen N. V.
9.2.5. Agilent Technologies Inc.
9.2.6. Revvity Inc.
9.2.7. Pacific Biosciences of California Inc
9.2.8. Danaher Corporation
9.2.9. Oxford Nanopore Technologies Plc.
9.2.10. MGI Tech Co. Ltd..
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們